Keyword: ISOL
Paper Title Other Keywords Page
MOP15 The ISOLPHARM Project for the Production of High Specific Activity Radionuclides for Medical Applications target, proton, ion, simulation 91
 
  • M. Ballan, A. Andrighetto, F. Borgna, S. Corradetti
    INFN/LNL, Legnaro (PD), Italy
  • M. Ballan
    UNIFE, Ferrara, Italy
  • F. Borgna, N. Realdon
    Università degli Studi di Padova, Padova, Italy
  • A. Duatti
    Università degli Studi di Ferrara, Ferrara, Italy
 
  ISOLPHARM is a branch of the INFN-LNL SPES project*, aimed at the production of radioisotopes for medical applications according to the ISOL technique. Such an innovative method will allow to obtain radiopharmaceuticals with very high specific activity. In this context a primary proton beam, extracted from a cyclotron will directly impinge a target, where the produced isotopes are extracted and accelerated, and finally, after mass separation, only the desired nuclei are deposed on a secondary target. This work is focused in the design and study of the aforementioned production targets for a selected set of isotopes, in particular for 64Cu, 89Sr, 90Y, 125I and 131I. 64Cu will be produced impinging Ni targets, otherwise the SPES UCx target is planned to be used. Different target configurations are being studied by means of the Monte Carlo based code FLUKA for the isotope production calculation and the Finite Element Method based software ANSYS ® for the temperature level evaluation. An appropriate secondary target substrate for implanting the produced isotopes is under study alongside with a system for its dissolution and repartition into radiopharmaceutical doses.
* A. Monetti et al., The RIB production target for the SPES project, Eur. Phys. J. A (2015) 51:128
 
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)  
 
THP22 Status of the ISOL Cyclotron System in RISP cyclotron, target, proton, controls 356
 
  • J. Kang, H.M. Jang, B. Kang, J.-W. Kim, J.H. Lee
    IBS, Daejeon, Republic of Korea
 
  An ISOL system has been developed for providing neutron-rich RI beam to multi-disciplinary users by Rare Isotope Science Project (RISP) of the Institute for Basic Science (IBS) in Korea. The ISOL system is composed of proton driver, target/ion source station, mass separator, charge breeder, and A/q separator. A selected beam of interest is then injected into re-accelerator, which is a superconducting linac. A 70-MeV proton cyclotron was chosen as the proton driver to induce direct fission of UCx target. The final goal of beam power on target is 70 kW, which will be achieved gradually from 10 kW during post-RISP. Commercial H compact cyclotrons and high-intensity separated cyclotrons have been considered for its extension of multi-purpose uses. In this paper, the specifications of the cyclotrons along with concerned issues and the status of our procurement plan will be presented.  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)  
 
FRA03 Status of the High Intensity Proton Beam Facility at LNL cyclotron, proton, target, neutron 394
 
  • M. Maggiore, P. Antonini, D. Benini, G. Bisoffi, E. Boratto, M. Calderolla, A. Calore, D. Campo, N. Ciatara, J. Esposito, P. Favaron, A. Lombardi, L. Pranovi, G.P. Prete, L. Sarchiapone, D. Scarpa, D. Zafiropoulos, L. de Ruvo
    INFN/LNL, Legnaro (PD), Italy
 
  In 2013 the SPES (Selective Production of Exotic Species) project has entered in the construction phase at Laboratori Nazionali di Legnaro (LNL). The project, whose main goal is the research in nuclear physics with Radioactive Beams, has foreseen the construction of a new building hosting the accelerator able to deliver protons up the energy of 70 MeV and 50kW of beam power to be used as a primary beam for the ISOL source and for a production beam for other applications. The new facility design has been expanded and upgraded for taking advantage of the dual simultaneous extraction of beams from the Cyclotron in order to provide a multipurpose high intensity irradiation facility. Today the new facility is partially installed and the Cyclotron supplied by BEST Theratronics company (CANADA) with the related beam transport lines are under commissioning. The status of the commissioning of the high power accelerator and the capabilities of the facility as multipurpose high intensity proton beam laboratory will be presented.  
slides icon Slides FRA03 [18.295 MB]  
Export • reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)